Novo Nordisk EBIT 2010-2024 | NVO

Novo Nordisk EBIT for the quarter ending June 30, 2024 was $3.742B, a 7.23% increase year-over-year.

  • Novo Nordisk 2023 EBIT was 14.894B, a 40.6% increase from 2022.
  • Novo Nordisk 2022 EBIT was 10.593B, a 13.53% increase from 2021.
  • Novo Nordisk 2021 EBIT was 9.33B, a 12.52% increase from 2020.

EBIT can be defined as earnings before interest and taxes.

Novo Nordisk EBIT 2010-2024 | NVO

  • Novo Nordisk 2023 EBIT was 14.894B, a 40.6% increase from 2022.
  • Novo Nordisk 2022 EBIT was 10.593B, a 13.53% increase from 2021.
  • Novo Nordisk 2021 EBIT was 9.33B, a 12.52% increase from 2020.

EBIT can be defined as earnings before interest and taxes.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$861.3B
Johnson & Johnson (JNJ)$402.2B
AbbVie (ABBV)$341.7B
Merck (MRK)$299.6B
AstraZeneca (AZN)$243.5B
Novartis AG (NVS)$236.5B
Pfizer (PFE)$169B
Sanofi (SNY)$144.1B
Innoviva (INVA)$1.2B